Cargando…

Promoter Polymorphism of RGS2 Gene Is Associated with Change of Blood Pressure in Subjects with Antihypertensive Treatment: The Azelnidipine and Temocapril in Hypertensive Patients with Type 2 Diabetes Study

We performed a prospective study to examine the genetic effect on the response to a calcium (Ca) channel blocker, azelnidipine and an ACE inhibitor, temocapril treatment in patients with hypertension, as a part of the prior clinical trial, the Azelnidipine and Temocapril in Hypertensive Patients wit...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sugimoto, Ken, Katsuya, Tomohiro, Kamide, Kei, Fujisawa, Tomomi, Shimaoka, Izumi, Ohishi, Mitsuru, Morishita, Ryuichi, Ogihara, Toshio, Rakugi, Hiromi
Formato:	Texto
Lenguaje:	English
Publicado:	SAGE-Hindawi Access to Research 2010
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2958339/ https://www.ncbi.nlm.nih.gov/pubmed/20981351 http://dx.doi.org/10.4061/2010/196307

Ejemplares similares

ANRIL: Molecular Mechanisms and Implications in Human Health
por: Congrains, Ada, et al.
Publicado: (2013)

Tumor‐selective Blood Flow Decrease Induced by an Angiotensin Converting Enzyme Inhibitor, Temocapril Hydrochloride
por: Hori, Katsuyoshi, et al.
Publicado: (2000)

Vascular microarray profiling in two models of hypertension identifies caveolin-1, Rgs2 and Rgs5 as antihypertensive targets
por: Grayson, T Hilton, et al.
Publicado: (2007)

Effects of ipragliflozin on left ventricular diastolic function in patients with type 2 diabetes and heart failure with preserved ejection fraction: The EXCEED randomized controlled multicenter study
por: Akasaka, Hiroshi, et al.
Publicado: (2022)

Analysis of antihypertensive treatment using real-world Japanese data—the retrospective study of antihypertensives for lowering blood pressure (REAL) study
por: Ohishi, Mitsuru, et al.
Publicado: (2019)

Inhibitory Effects of Azelnidipine Tablets on Morning Hypertension
por: Kario, Kazuomi, et al.
Publicado: (2013)

Azelnidipine, but not amlodipine, reduces urinary albumin excretion and carotid atherosclerosis in subjects with type 2 diabetes: blood pressure control with olmesartan and azelnidipine in Type 2 diabetes (BOAT2 study)
por: Tawaramoto, Kazuhito, et al.
Publicado: (2015)

Response to Comment on: Takeda et al. Loss of ACE2 Exaggerates High-Calorie Diet–Induced Insulin Resistance by Reduction of GLUT4 in Mice. Diabetes 2013;62:223–233
por: Yamamoto, Koichi, et al.
Publicado: (2013)

Loss of ACE2 Exaggerates High-Calorie Diet–Induced Insulin Resistance by Reduction of GLUT4 in Mice
por: Takeda, Masao, et al.
Publicado: (2013)

Azelnidipine protects myocardium in hyperglycemia-induced cardiac damage
por: Kain, Vasundhara, et al.
Publicado: (2010)

Clinical use of azelnidipine in the treatment of hypertension in Chinese patients
por: Chen, Bi-Lian, et al.
Publicado: (2015)

Insight into the Role of Angiopoietins in Ageing-Associated Diseases
por: Hayashi, Shin-ichiro, et al.
Publicado: (2020)

Antihypertensive effects and safety of esaxerenone in patients with moderate kidney dysfunction
por: Ito, Sadayoshi, et al.
Publicado: (2020)

A klotho gene single nucleotide polymorphism is associated with the onset of stroke and plasma klotho concentration
por: Yokoyama, Serina, et al.
Publicado: (2018)

Cardiac and Renal Protective Effects of Irbesartan via Peroxisome Proliferator‐Activated Receptorγ–Hepatocyte Growth Factor Pathway Independent of Angiotensin II Type 1a Receptor Blockade in Mouse Model of Salt‐Sensitive Hypertension
por: Kusunoki, Hiroshi, et al.
Publicado: (2013)

Lower body mass index potentiates the association between skipping breakfast and prevalence of proteinuria
por: Muratsu, Jun, et al.
Publicado: (2022)

Decrease in Blood Pressure and Regression of Cardiovascular Complications by Angiotensin II Vaccine in Mice
por: Nakagami, Futoshi, et al.
Publicado: (2013)

Low alpha-synuclein levels in the blood are associated with insulin resistance
por: Rodriguez-Araujo, Gerardo, et al.
Publicado: (2015)

The Muscle Thickness Assessment Using Ultrasonography is a Useful Alternative to Skeletal Muscle Mass by Bioelectrical Impedance Analysis
por: Isaka, Masaaki, et al.
Publicado: (2022)

Possible modification of Alzheimer’s disease by statins in midlife: interactions with genetic and non-genetic risk factors
por: Shinohara, Mitsuru, et al.
Publicado: (2014)

Effects of calcium channel blocker-based combinations on intra-individual blood pressure variability: post hoc analysis of the COPE trial
por: Umemoto, Seiji, et al.
Publicado: (2016)

Effects of calcium channel blocker benidipine-based combination therapy on target blood pressure control and cardiovascular outcome: a sub-analysis of the COPE trial
por: Umemoto, Seiji, et al.
Publicado: (2017)

The Combination of High Levels of Adiponectin and Insulin Resistance Are Affected by Aging in Non-Obese Old Peoples
por: Muratsu, Jun, et al.
Publicado: (2022)

Therapeutic vaccine for chronic diseases after the COVID-19 Era
por: Nakagami, Hironori, et al.
Publicado: (2021)

Comparison of the physical and thermodynamic stability of amorphous azelnidipine and its coamorphous phase with piperazine
por: Du, Shuang, et al.
Publicado: (2018)

A case of complete atrioventricular block with extremely high blood concentration of azelnidipine
por: Ide, Naohito, et al.
Publicado: (2021)

Rationale and design of a multicenter randomized study comparing the efficacy and safety of esaxerenone versus trichlormethiazide in patients with uncontrolled essential hypertension: EXCITE‐HT study
por: Kario, Kazuomi, et al.
Publicado: (2023)

Long-term phase 3 study of esaxerenone as mono or combination therapy with other antihypertensive drugs in patients with essential hypertension
por: Rakugi, Hiromi, et al.
Publicado: (2019)

The RGS2 (-391, C>G) Genetic Variation Correlates to Antihypertensive Drug Responses in Chinese Patients with Essential Hypertension
por: He, Fazhong, et al.
Publicado: (2015)

Genetics of Hypertension and Cardiovascular Disease
por: Katsuya, Tomohiro, et al.
Publicado: (2011)

Association of Genetic Variants Influencing Lipid Levels with Coronary Artery Disease in Japanese Individuals
por: Takeuchi, Fumihiko, et al.
Publicado: (2012)

Therapeutic Angiogenesis Using HGF Plasmid
por: Sanada, Fumihiro, et al.
Publicado: (2020)

Potential protective effects of Azelnidipine against cerebral ischemia-reperfusion injury in male rats
por: Fakharaldeen, Zainab, et al.
Publicado: (2022)

Early detection of cognitive impairment by natural language among outpatients and community dwellers
por: Kiyoshige, Eri, et al.
Publicado: (2020)

Azelnidipine Inhibits the Differentiation and Activation of THP-1 Macrophages through the L-Type Calcium Channel
por: Komoda, Hiroshi, et al.
Publicado: (2018)

Azelnidipine may be a valuable drug for chemoprevention of ESCC with high MEK1/2 levels
por: Qian, Haili
Publicado: (2022)

A Novel Therapeutic Peptide as a Partial Agonist of RANKL in Ischemic Stroke
por: Kurinami, Hitomi, et al.
Publicado: (2016)

Source of Chronic Inflammation in Aging
por: Sanada, Fumihiro, et al.
Publicado: (2018)

IGF Binding Protein-5 Induces Cell Senescence
por: Sanada, Fumihiro, et al.
Publicado: (2018)

Gene-Therapeutic Strategies Targeting Angiogenesis in Peripheral Artery Disease
por: Sanada, Fumihiro, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_3s2tvr3sqmqs6lhbnnvpmqdlnc